CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Modulating tumor physical microenvironment for fueling CAR-T cell therapy.
Modulating tumor physical microenvironment for fueling CAR-T cell therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T细胞疗法在血液系统恶性肿瘤中取得了前所未有的临床成功。然而,CAR-T 细胞疗法向实体瘤的转化受到抗原表达异质性、免疫抑制微环境(TME)、肿瘤细胞的免疫适应以及CAR-T 细胞浸润/运输受阻的限制。近年来越来越多的研究表明,肿瘤物理微环境可影响肿瘤生物学的多个方面,并对CAR-T 疗法的抗肿瘤疗效产生深远影响。在这篇综述中,我们讨论了实体瘤中四种物理线索在调节CAR-T 细胞免疫应答中的关键作用,包括固体应力、间质液压力、硬度和微结构。我们通过与该领域最先进技术相结合,重点介绍了利用这些特征来增强CAR-T 细胞在实体瘤中治疗效力的新策略。此外,还提供了关于开发用于实体瘤治疗的新型CAR-T 疗法的未来方向的展望。
Chimeric antigen receptor (CAR) T cell therapy has achieved unprecedented clinical success against hematologic malignancies.
However, the transition of CAR-T cell therapies for solid tumors is limited by heterogenous antigen expression, immunosuppressive microenvironment (TME), immune adaptation of tumor cells and impeded CAR-T-cell infiltration/transportation.
Recent studies increasingly reveal that tumor physical microenvironment could affect various aspects of tumor biology and impose profound impacts on the antitumor efficacy of CAR-T therapy. In this review, we discuss the critical roles of four physical cues in solid tumors for regulating the immune responses of CAR-T cells, which include solid stress, interstitial fluid pressure, stiffness and microarchitecture.
We highlight new strategies exploiting these features to enhance the therapeutic potency of CAR-T cells in solid tumors by correlating with the state-of-the-art technologies in this field. A perspective on the future directions for developing new CAR-T therapies for solid tumor treatment is also provided.
MEMBER ACCOUNT
登录成功会直接打开下一页。